201
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Systemic Immune–Inflammation Index Predicts New-Onset Atrial Fibrillation After St Elevation Myocardial Infarction

ORCID Icon & ORCID Icon
Pages 731-739 | Received 01 Dec 2020, Accepted 04 Mar 2021, Published online: 22 Jun 2021

References

  • Kirchhoff P , BenussiS, KotechaD. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC, endorsed by the European Stroke Organization (ESO). Eur. Heart J.37(38), 2893–2962 (2016).
  • Bas HA , AksoyF, IcliAet al. The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction. Scand. J. Clin. Lab. Invest.77(2), 77–82 (2017).
  • Ozaydin M . Atrial fibrillation and inflammation. World J. Cardiol.2(8), 243 (2010).
  • Liu Y , ShiQ, MaYet al. The role of immune cells in atrial fibrillation. J. Mol. Cell. Cardiol.123, 198–208 (2018).
  • Dong G , HuangA, LiuL. Platelet-to-lymphocyte ratio and prognosis in STEMI: a meta-analysis. Eur. J. Clin. Invest.51(3), e13386 (2021).
  • Afari ME , BhatT. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev. Cardiovasc. Ther.14(5), 573–577 (2016).
  • Kim Y , ChoiH, JungSMet al. Systemic immune–inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naïve patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology24(7), 711–717 (2019).
  • Agus HZ , KahramanS, ArslanCet al. Systemic immune–inflammation index predicts mortality in infective endocarditis. J. Saudi Heart Assoc.32(1), 58–64 (2020).
  • Erdoğan M , ErdölMA, ÖztürkSet al. Systemic immune–inflammation index is a novel marker to predict functionally significant coronary artery stenosis. Biomark. Med.14(16), 1553–1561 (2020).
  • Lang RM , BierigM, DevereuxRBet al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiog.18(12), 1440–1463 (2005).
  • Thygesen K , AlpertJS, JaffeASet al. Fourth universal definition of myocardial infarction (2018). J. Am. Coll. Cardiol.72(18), 2231–2264 (2018).
  • Ibanez B , JamesS, AgewallSet al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J.39(2), 119–177 (2018).
  • Schmitt J , DurayG, GershBJet al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur. Heart J.30(9), 1038–1045 (2009).
  • Baş HA , BağcıA, AksoyF. Usefulness of mean platelet volume and neutrophil-to-lymphocyte ratio for development of atrial fibrillation after acute myocardial infarction. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi10(3), 278–283 (2019).
  • Guo Y , LipGY, ApostolakisS. Inflammation in atrial fibrillation. J. Am. Coll. Cardiol.60(22), 2263–2270 (2012).
  • Boos CJ , AndersonRA, LipGY. Is atrial fibrillation an inflammatory disorder?Eur. Heart J.27(2), 136–149 (2006).
  • Wu Z-K , LaurikkaJ, VikmanSet al. High postoperative interleukin-8 levels related to atrial fibrillation in patients undergoing coronary artery bypass surgery. World J. Surg.32(12), 2643–2649 (2008).
  • Aksoy F , UysalD, IbrişimE. Predictive values of C-reactive protein/albumin ratio in new-onset atrial fibrillation after coronary artery bypass grafting. Revista da Associação Médica Brasileira66(8), 1049–1056 (2020).
  • Yang YL , WuCH, HsuPFet al. Systemic immune–inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur. J. Clin. Invest.50(5), e13230 (2020).
  • Aslan G , Atarİ. anti-arrhythmic properties of ACE inhibitors and the use of in arrhythmia. Curr. Int. Med. J.3, 39–46 (2009).
  • Frustaci A , ChimentiC, BellocciFet al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation96(4), 1180–1184 (1997).
  • Ozaydin M , TurkerY, ErdoganDet al. The association between previous statin use and development of atrial fibrillation in patients presenting with acute coronary syndrome. Int. J. Cardiol.141(2), 147–150 (2010).
  • Arslan A , OzaydinM, AksoyFet al. Association between the use of renin–angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction. Medicina52(2), 104–109 (2016).
  • Aksoy F , BaşHA, BağcıAet al. The CHA2DS2-VASc score for predicting atrial fibrillation in patients presenting with ST elevation myocardial infarction: prospective observational study. Sao Paulo Med. J.137(3), 248–254 (2019).
  • Vaziri SM , LarsonMG, BenjaminEJet al. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation89(2), 724–730 (1994).
  • Mehta RH , DabbousOH, GrangerCBet al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am. J. Cardiol.92(9), 1031–1036 (2003).
  • Al-Khatib SM , PieperKS, LeeKLet al. Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. Am. J. Cardiol.88(1), 76–79 (2001).
  • Kirchhof P , BenussiS, KotechaDet al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. J. Cardiothorac. Surg.70(1), 50 (2017).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.